Results 21 to 30 of about 1,483,959 (183)
Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation [PDF]
Key Clinical Message Hematopoietic neoplasms can cause adrenal infarction. In cases of thrombosis occurring at uncommon sites, it is necessary to consider evaluating for the JAK2V617F mutation, even in the absence of notable abnormalities in blood counts.
Shunichiro Yasuda +3 more
doaj +2 more sources
Association of polycythemia vera with positive JAK2V617F mutation and myasthenia gravis: A report of two cases [PDF]
Screening for MG in patients with PV positive for JAK2V617F mutation can help in early diagnosis and treatment, resulting in a significant reduction in morbidity and mortality.
Sreethish Sasi +3 more
doaj +2 more sources
Melting curve analysis after T allele enrichment (MelcaTle) as a highly sensitive and reliable method for detecting the JAK2V617F mutation. [PDF]
Detection of the JAK2V617F mutation is essential for diagnosing patients with classical myeloproliferative neoplasms (MPNs). However, detection of the low-frequency JAK2V617F mutation is a challenging task due to the necessity of discriminating between ...
Soji Morishita +9 more
doaj +2 more sources
Background: Whether inflammation is independently associated with development of JAK2V617F mutation and myeloproliferative neoplasm is not clear. We tested the hypothesis that a loss-of-function polymorphism in IL6R (marked by rs4537545) reduces risk of ...
Kasper Mønsted Pedersen +5 more
doaj +2 more sources
Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms
OBJECTIVE/BACKGROUND: Myeloproliferative neoplasms (MPNs) are heterogeneous clonal bone marrow stem cell disorders and include polycythemia vera (PV), essential thrombocythemia (ET), and idiopathic myelofibrosis (IMF) neoplasia.
Saied A Jaradat +6 more
doaj +2 more sources
Objectives: Our aim was to explore the relationship between JAK2V617F mutation allele burden and hematological parameters especially in coagulation function in Chinese population. Methods: This study included 133 Ph-negative myeloproliferative neoplasms (
Shudao Xiong +2 more
exaly +2 more sources
Investigation of JAK2V617F Mutation Prevalence in Patients with Beta Thalassemia Major. [PDF]
BACKGROUND Beta (β)-thalassemia major is a genetic disorder with anemia and an increased level of erythropoietin by Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway.
Zari Tahannejad Asadi +5 more
semanticscholar +3 more sources
Ipek Yonal-Hindilerden, Aynur Daglar-Aday, Basak Akadam-Teker, Ceylan Yilmaz, Meliha Nalcaci, Akif Selim Yavuz, Deniz SarginDivision of Hematology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Fatih-Istanbul, Turkey ...
Yonal-Hindilerden I +6 more
doaj +5 more sources
BCR-ABL and JAK2V617F Mutation Co-existence, Rare or Just Unexplored. [PDF]
Darling HS +4 more
europepmc +2 more sources
Budd-Chiari syndrome on background of JAK2V617F mutation with no hematologic abnormalities. [PDF]
AbstractWhenever considering idiopathic Budd‐Chiari syndrome, consider the possibility of JAK2 mutation even if clinical parameters are within normal range.
Bint I Bilal A +3 more
europepmc +5 more sources

